Ruth Berenguer-Gasparini
Alicante, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease.
Journal: Frontiers in neurology
Published: December 14, 2022
Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer's Disease.
Journal: Medicina (Kaunas, Lithuania)
Published: July 21, 2021
Frequent involvement of the amyloid pathway in prodromal dementia with Lewy bodies
Journal: Revista de neurologia
Published: July 17, 2019
Measurement of CSF α-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.
Journal: Journal of neurochemistry
Published: December 21, 2018
Diagnostic Validity Comparison Between Criteria Based on CSF Alzheimer's Disease Biomarkers.
Journal: American journal of Alzheimer's disease and other dementias
Published: February 14, 2017
Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population.
Journal: BioMed research international
Published: August 06, 2015
Comparison of two analytical platforms for CSF biomarkers of Alzheimer's disease.
Journal: BioMed research international
Published: February 10, 2014
A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid.
Journal: Neurologia (Barcelona, Spain)
Published: January 28, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026